Upgrade to SI Premium - Free Trial

Incyte to acquire Vega Therapeutics for $1.25 billion upfront

June 8, 2026 7:00 AM
Incyte Corp. (NASDAQ: INCY) announced it has entered into a definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Mergers and Acquisitions